Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirolimus for acquired chronic pure red cell aplasia relapsed/refractory to cyclosporine A
jRCT2031240482Phase 3Active, not recruiting
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in pure red cell aplasia (PRCA) comparing Sirolimus with Placebo (2 arms). Started Dec 2024; status: active, not recruiting.
02
Drugs
sirolimus
03
Conditions
pure red cell aplasia (PRCA)
Beyond the preview
Go deeper on jRCT2031240482.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031240482.